Dignitana AB

Equities

DIGN

SE0002108001

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 08:59:44 28/05/2024 pm IST			5-day change	1st Jan Change
2.15 ^SEK	-1.38%		+43.33%	-1.38%

23/05	Dignitana AB Approves the Election of Fredrik Lindgren and Hope S. Rugo as Board Members	CI
23/05	Dignitana AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Dignitana AB Appoints Ulf Jönsson as Chief Financial Officer

May 17, 2022 at 01:00 pm IST

Dignitana AB (publ) announced Ulf Jönsson has been appointed Chief Financial Officer, effective 1 July 2022. He is currently Interim Group Operations Controller for Diab International AB and was previously CFO for MalmbergGruppen. He spent 10 years with global med tech Gambro AB as Controller and then Director of Finance prior to the Company's 2013 acquisition by Baxter.

Latest news about Dignitana AB

Dignitana AB Approves the Election of Fredrik Lindgren and Hope S. Rugo as Board Members	23/05	CI
Dignitana AB Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05	CI
Dignitana, Konica Minolta Enter Multi-year Exclusive Distribution Deal in Japan	21/05	MT
Dignitana AB Announces Chief Executive Officer Changes , Effective May 2, 2024	24/04	CI
Dignitana Raises SEK19 Million via Rights Issue of Shares	04/04	MT
Dignicap Delta Study Underway in Brindisi, Italy	07/03	CI
Sweden's Dignitana to Raise SEK19 Million via Rights Issues, Secures SEK5 Million Bridge Loan	22/02	MT
Dignitana AB Reports Earnings Results for the Full Year Ended December 31, 2023	15/02	CI
Dignitana AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02	CI
Dignitana Receives Japanese Market Approval for Medical Device for Cancer Patients	12/02	MT
Dignitana Announces DigniCap Delta Receives Market Approval in Japan	12/02	CI
Dignitana Announces Preliminary Results of DigniCap Delta Study Demonstrates 79% Efficacy	16/01	CI
Dignitana Signs Exclusive Distribution Deal with OncoMedical	15/01	MT
Dignitana AB Signs OncoMedical AG for Distribution in Switzerland and Liechtenstein	15/01	CI
Dignitana AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11	CI
Dignitana AB Appoints Nomination Committee	07/11	CI
Dignitana Signs Sales & Marketing Deal With US-based InfuSystem; Shares Drop	04/23/04	MT
Dignitana AB Announces Sales and Marketing Partnership with InfuSystem Holdings, Inc. to Provide Scalp Cooling Systems in the United States	04/23/04	CI
Palmetto GBA Medicare Contractor Backs Dignitana's Scalp Cooling Solution for Cancer Patients	03/23/03	MT
Dignitana AB Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	03/23/03	CI
Dignitana AB Long-Term Study Demonstrates Safety and Efficacy of Scalp Cooling to Reduce Chemo Hair Loss	17/23/17	CI
Dignitana AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17	CI
Dignitana Expands Oneservice Collaboration to Include DigniCap Delta	17/23/17	MT
Dignitana AB Expands Customer Service Coverage in Europe with Oneservice Partnership	17/23/17	CI
Dignitana to Deliver Improved Scalp Cooling Technology to Minimize Chemotherapy-induced Hair Loss in Mexico	17/23/17	MT

Chart Dignitana AB

Duration

Period

More charts

Company Profile

Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold cap, which when put on the patientâs head, lowers the temperature of the scalp. The low temperature reduces perfusion, delivery of blood and metabolism. The reduced blood flow results in a smaller amount of chemotherapy available for uptake in the cells, while the decreased temperature results in less absorption and reduced effects of chemotherapy. These factors together reduce the risk of hair loss. The DigniCap scalp cooling system is patented in Europe, Japan and the United States. It has a subsidiary BrainCool AB, which focuses on producing different models of brain cooling for stroke and cardiac arrest patients.

Sector

Medical Equipment, Supplies & Distribution

Calendar

22/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Dignitana AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
DIGNITANA AB	-1.38%	1.45Cr
SHOCKWAVE MEDICAL, INC.	+75.57%	1.25TCr
PENUMBRA, INC.	-23.00%	750.72Cr
MASIMO CORPORATION	+8.83%	674.19Cr
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+14.95%	548.43Cr
GETINGE AB	-14.65%	493.23Cr
APT MEDICAL INC.	+30.59%	471.27Cr
ASAHI INTECC CO., LTD.	-24.40%	382.99Cr
INARI MEDICAL, INC.	-22.66%	290.4Cr
NOVOCURE LIMITED	+48.63%	249.12Cr

Medical Equipment